Clinical Experiences and Results of Application of Mitomycin C in Trabeculectomy;Klinische Erfahrungen und Ergebnisse beim Einsatz von Mitomycin C bei der Trabekulektomie

Klinische Monatsblatter fur Augenheilkunde

Volumn 220, Issue 9, 2003, Pages 618-624

  Laube, Thomas ^a   Ritters, Birgit ^a   Selbach, Michael ^a   Hudde, Tobias ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Choroidal detachment; Glaucoma; Hypotonia; Intraocular pressure; Mitomycin C (MMC)

Indexed keywords

CARBONATE DEHYDRATASE INHIBITOR; MITOMYCIN; MITOMYCIN C;

ADULT; AGED; ARTICLE; CHOROID DETACHMENT; CHOROID DISEASE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; IATROGENIC DISEASE; INTRAOCULAR PRESSURE; LENS IMPLANT; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MUSCLE HYPOTONIA; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; REOPERATION; RETROSPECTIVE STUDY; RISK FACTOR; TRABECULECTOMY; VISUAL ACUITY; WOUND HEALING; WOUND HEALING IMPAIRMENT;

AGED; CHOROID DISEASES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; LENSES, INTRAOCULAR; MALE; MIDDLE AGED; MITOMYCIN; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TRABECULECTOMY; VISUAL ACUITY; WOUND HEALING;

EID: 0142153098     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42808     Document Type: Article

References (27)

1. Agarwal HC, Sharma TK, Sihota R, Gulati V. Cumulative effect of risk factors on short-term surgical success of mitomycin augmented trabeculectomy. J Postgrad Med 2002; 48: 92-96
2. Annen DJ, Sturmer J. Verlauf einer Pilotstudie zur Trabekulectomie mit niedrig konzentriertem Mitomycin C (0,2 mg/ml für 1 Minute). Unabhängige Auswertung einer retrospektiven nicht randomisierten Studie. Klin Monatsbl Augenheilkd 1995; 206: 300-302
3. Bindlish R, Condon GP, Schlosser JD, D'Antonio J, Lauer KB et al. Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up. Ophthalmology 2002; 109: 1336-1341; discussion 1341-1332
4. Casson R, Rahman R, Salmon JF. Long-term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure. Br J Ophthalmol 2001; 85: 686-688
5. Cheung JC, Wright MM, Murali S, Pederson JE. Intermediate-term out-come of variable dose mitomycin C filtering surgery. Ophthalmology 1997; 104: 143-149
6. DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 2002; 120: 297-300
7. Diestelhorst M, Krieglstein GK. Der Einfluss von Mitomycin C auf die Kammerwassersekretion nach Trabekulektomie. Ophthalmologe 1995; 92: 542-545
8. Gaspar AZ, Orgul S, Flammer J. Erfahrungen mit Mitomycin C. Klin Monatsbl Augenheilkd 1994; 204: 295-297
9. Hayashi K, Hayashi H, Nakao F, Hayashi F. Effect of cataract surgery on intraocular pressure control in glaucoma patients. J Cataract Refract Surg 2001; 27: 1779-1786
10. Jacobi PC, Dietlein TS, Krieglstein GK. Adjunctive mitomycin C in primary trabeculectomy in young adults: a long-term study of casematched young patients. Graefes Arch Clin Exp Ophthalmol 1998; 236: 652-657
11. Kidd MN, O'Connor M. Progression of field loss after trabeculectomy: a five-year follow-up. Br J Ophthalmol 1985; 69: 827-831
12. Kitazawa Y, Suemori-Matsushita H, Yamamoto T, Kawase K. Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. Ophthalmology 1993; 100: 1624-1628
13. Krommes G, Lieb W, Grehn F. Standardization of the dose of intraoperative mitomycin C in trabeculectomy. Graefes Arch Clin Exp Ophthalmol 2002; 240: 594-595
14. Mao LK, Stewart WC, Shields MB. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol 1991; 111: 51-55
15. Martini E, Laffi GL, Sprovieri C, Scorolli L. Low-dosage mitomycin C as an adjunct to trabeculectomy. A prospective controlled study. Eur J Ophthalmol 1997; 7: 40-48
16. Mietz H, Addicks K, Diestelhorst M, Krieglstein GK. Extraocular application of mitomycin C in a rabbit model: cytotoxic effects on the ciliary body and epithelium. Ophthalmic Surg 1994; 25: 240-244
17. Mietz H, Krieglstein GK. Short-term clinical results and complications of trabeculectomies performed with mitomycin C using different concentrations. Int Ophthalmol 1995; 19: 51-56
18. Mietz H, Krieglstein GK. Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C. Ophthalmic Surg Lasers 1998; 29: 628-634
19. Pfeiffer N. Rückblick zur Glaukomforschung. Klin Monatsbl Augenheilkd 1993; 203: 1-9
20. Popovic V, Sjostrand J. Long-term outcome following trabeculectomy: II Visual field survival. Acta Ophthalmol (Copenh) 1991; 69: 305-309
21. Robin AL, Ramakrishnan R, Krishnadas R, Smith SD, Katz JD et al. A long-term dose-response study of mitomycin in glaucoma filtration surgery. Arch Ophthalmol 1997; 115: 969-974
22. Sanders SP, Cantor LB, Dobler AA, Hoop JS. Mitomycin C in higher risk trabeculectomy: a prospective comparison of 0.2- to 0.4-mg/cc doses. J Glaucoma 1999; 8: 193-198
23. Schraermeyer U, Diestelhorst M, Bieker A, Theisohn M, Mietz H et al. Morphologic proof of the toxicity of mitomycin C on the ciliary body in relation to different application methods. Graefes Arch Clin Exp Ophthalmol 1999; 237: 593-600
24. Spaeth GL, Mutlukan E. The use of antimetabolites with trabeculectomy: a critical appraisal. J Glaucoma 2001; 10: 145-151
25. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130: 429-440
26. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 1995; 113: 216-221
27. Wilkins M, Indar A, Wormald R. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev, 2001; 1